Pricing Log in Create free account

Hyperfine, Inc. (HYPR) vs Sera Prognostics, Inc. (SERA)

Hyperfine, Inc. and Sera Prognostics, Inc. are both Medical Devices companies. Sera Prognostics, Inc. is the larger, with a market value of $82.1M against $72.7M — 1.1× the size. Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against 1.05%. Hyperfine, Inc. has the higher net margin (−210.8% vs −34,866.7%) and the lower return on invested capital (−401.8% vs −278.6%). Across the 18 metrics below, Hyperfine, Inc. leads on 11 and Sera Prognostics, Inc. on 7.

Valuation

Metric HYPR SERA Medical Devices median
P/E n/m n/m 25.58
P/S 4.16 1,100.45 2.54
P/B 1.87 2.01 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 2.26 641.21 2.72
Earnings yield (55.07%) (32.21%) (12.82%)
Free cash flow yield (39.98%) (27.81%) (8.18%)

Profitability

Metric HYPR SERA Medical Devices median
Gross margin 51.41% 0.00% 57.76%
Operating margin (203.27%) (38,755.21%) (15.07%)
Net margin (210.75%) (34,866.67%) (14.45%)
Free cash flow margin (166.48%) (30,198.96%) (3.88%)
Return on equity (96.97%) (49.73%) (10.35%)
Return on assets (64.40%) (35.59%) (17.26%)
Return on invested capital (401.79%) (278.58%) (5.27%)

Growth

Metric HYPR SERA Medical Devices median
Revenue growth (TTM) 53.16% 1.05% 10.41%
EPS growth (last fiscal year) 23.21% 32.32% 28.17%
Revenue growth, 5-year CAGR 115.18% 26.51% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HYPR SERA Medical Devices median
Debt to equity 0.36 0.00 0.04
Current ratio 6.15 1.88 2.74
Net debt to EBITDA 1.00 1.10 0.54

Dividend

Metric HYPR SERA Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric HYPR SERA Medical Devices median
Market cap 72.69m 82.05m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack